Share this
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
Meredith Agrees to Sell National Media Group to IAC’s Dotdash
ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million
Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion
Prothena Agrees to Sell ATTR Amyloidosis Program to Novo Nordisk
Horizon Therapeutics to Acquire Viela Bio
VelosBio Agrees to Sell to Merck for $2.75 Billion
Forbius Agrees to Sell to Bristol Myers Squibb
Synthorx to Sell to Sanofi for $2.5 Billion
Avedro Sells to Glaukos
Arlo to Partner with Verisure
Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million
SendGrid Sells to Twilio for $2 Billion
BroadSoft Sells to Cisco for $1.9 Billion
Sucampo Sells to Mallinckrodt for $1.2 Billion
EnerNOC Sells to Enel Group for More Than $300 Million
Horizon Pharma Buys River Vision for $145 Million and Unspecified Earn-Out
ZELTIQ Aesthetics to Sell to Allergan for $2.5 Billion
Jazz Pharmaceuticals Acquires Celator for $1.5 Billion
Horizon Pharma Acquisition of Crealta Holdings for $510 Million
Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb
NetScout Receives DOJ Clearance After Second Request in $2.6 Billion Acquisition
Auspex Pharma $3.5 billion sale to Teva Pharma
Auspex Pharma Acquired by Teva for $3.5 Billion
Horizon Pharma Acquires Hyperion Therapeutics for $1.1 Billion
CardioKinetix Completes $50 Million Financing
Volcano Corp. Acquired by Royal Philips NV for $1.2 Billion
Volcano Acquired by Philips for $1.2 Billion
NetScout Systems to Acquire Danaher Communications Business for $2.6B
Ambit Biosciences to be Acquired by Daiichi Sankyo for $410 Million
Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility
Horizon Pharma $660 Million Acquisition of Vidara Therapeutics
Coverity $375 Million Acquisition by Synopsys
Trius Therapeutics Acquisition by Cubist Pharmaceuticals
Websense $1 Billion Acquisition by Vista Equity
Hot Topic $600 Million Sale to Sycamore Partners